Immunogenicity of low-dose intradermal recombinant DNA hepatitis B vaccine.

Immunogenicity of a recombinant DNA hepatitis B vaccine in institutionalized patients with Down's syndrome.

Comparative immunogenicity in children of mammalian cell-derived recombinant hepatitis B vaccine and plasma-derived hepatitis B vaccine.

Heat stability of a recombinant DNA hepatitis B vaccine.

Complete seroconversion by low-dose intradermal injection of recombinant hepatitis B vaccine in hemodialysis patients.

Evaluation of thimerosal removal on immunogenicity of aluminum salts adjuvanted recombinant hepatitis B vaccine.

Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein--a preliminary study on immunogenicity.

Long-term immunogenicity safety and efficacy of a recombinant hepatitis B vaccine in healthy adults.

Immunogenicity of recombinant hepatitis B vaccine in urban black children from Ga-Rankuwa, Bophuthatswana, South Africa.

Intradermal hepatitis B vaccination.

Safety and immunogenicity of influenza vaccine among HIV-infected adults: Conventional vaccine vs. intradermal vaccine.

The immune response of low dose recombinant DNA hepatitis B vaccine in teenagers in Singapore.

The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy.

Comparative evaluation of the immunogenicity of yeast-derived (recombinant) and plasma-derived hepatitis B vaccine in infants.

Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens.

Comparison of a recombinant DNA hepatitis B vaccine alone or in combination with hepatitis B immune globulin for the prevention of perinatal acquisition of hepatitis B carriage.

Adverse reaction to the recombinant hepatitis B vaccine.

Evans's syndrome triggered by recombinant hepatitis B vaccine.

Immunogenicity of an inactivated hepatitis A vaccine.

Comparative trial of low-dose, intradermal, recombinant- and plasma-derived hepatitis B vaccines.

Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers.

Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine.

Hepatitis B vaccination: half dose recombinant DNA hepatitis B vaccine (B-Hepavac II) is as immunogenic as the full recommended dose in healthy adults.

Enhanced immunogenicity of an HIV-1 DNA vaccine delivered with electroporation via combined intramuscular and intradermal routes.

Comparison of immunogenicity of two yeast-derived recombinant hepatitis B vaccines.

Suggest Documents

Immunogenicity of a recombinant DNA hepatitis B vaccine in institutionalized patients with Down's syndrome.

Comparative immunogenicity in children of mammalian cell-derived recombinant hepatitis B vaccine and plasma-derived hepatitis B vaccine.

Heat stability of a recombinant DNA hepatitis B vaccine.

Complete seroconversion by low-dose intradermal injection of recombinant hepatitis B vaccine in hemodialysis patients.

Evaluation of thimerosal removal on immunogenicity of aluminum salts adjuvanted recombinant hepatitis B vaccine.

Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein--a preliminary study on immunogenicity.

Long-term immunogenicity safety and efficacy of a recombinant hepatitis B vaccine in healthy adults.

Immunogenicity of recombinant hepatitis B vaccine in urban black children from Ga-Rankuwa, Bophuthatswana, South Africa.

Intradermal hepatitis B vaccination.

Safety and immunogenicity of influenza vaccine among HIV-infected adults: Conventional vaccine vs. intradermal vaccine.

The immune response of low dose recombinant DNA hepatitis B vaccine in teenagers in Singapore.

The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy.

Comparative evaluation of the immunogenicity of yeast-derived (recombinant) and plasma-derived hepatitis B vaccine in infants.

Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens.

Comparison of a recombinant DNA hepatitis B vaccine alone or in combination with hepatitis B immune globulin for the prevention of perinatal acquisition of hepatitis B carriage.

Adverse reaction to the recombinant hepatitis B vaccine.

Evans's syndrome triggered by recombinant hepatitis B vaccine.

Immunogenicity of an inactivated hepatitis A vaccine.

Comparative trial of low-dose, intradermal, recombinant- and plasma-derived hepatitis B vaccines.

Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers.

Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine.

Hepatitis B vaccination: half dose recombinant DNA hepatitis B vaccine (B-Hepavac II) is as immunogenic as the full recommended dose in healthy adults.

Enhanced immunogenicity of an HIV-1 DNA vaccine delivered with electroporation via combined intramuscular and intradermal routes.

Comparison of immunogenicity of two yeast-derived recombinant hepatitis B vaccines.

Immunogenicity of low-dose intradermal recombinant DNA hepatitis B vaccine.

Recommend Documents

Follow Us